Accomplishment by a Senior Scientist Award: Webb Miller
Established in 2003, ISCB's Accomplishment by a Senior Scientist Award recognizes members of the computational biology community who have made major contributions to the field through research, education, service, or a combination of the three. Miller will be joining a prestigious group of previous winners: David Sankoff (University of Ottawa, Canada), David Lipman (US National Center for Biotechnology Information, USA), Janet Thornton (European Bioinformatics Institute, United Kingdom (UK)), Mike Waterman (University of Southern California, USA), Temple Smith (Boston University, USA), and David Haussler (University of California Santa Cruz, USA).
Ten years ago, the name Webb Miller was already well-known to bioinformaticians worldwide for two very highly cited classic papers on the BLAST algorithms for searching sequence databases [1, 2] . In recognizing an author of a widely used algorithm with the Senior Scientist Award, ISCB is continuing a tradition: the three most recent winners of this Award, David Haussler, and Temple Smith and Michael Waterman, are associated, respectively, with Hidden Markov Models and the eponymous Smith-Waterman sequence alignment algorithm. Today, however, Miller's name is equally well-known for the alignment, comparison, and analysis of complete vertebrate genomes. Much of the code written in his group is embedded in the University of California Santa Cruz (UCSC) Genome Browser, through which these algorithms penetrate as widely into the bioinformatics and genomics community as the ever-popular BLAST.
Miller with the rate of progress. ''It has been easier to sequence genomes, but harder to understand their biology than I, coming from a computer science background, thought it would [be],'' he says. ''It seems that biology is even more complex than we had assumed.'' He and his collaborators have now taken on a new challenge: sequencing the genomes and understanding the biology of rare, endangered, and even extinct species. He has published sequences of the nuclear genome of the woolly mammoth [4] and the mitochondrial genome of the Tasmanian tiger (Thylacinus cynocephalus) [5] , which became extinct in 1936. The DNA samples for the latter project were obtained from specimens that had been preserved for decades in museums. Miller says he is hoping that similar sequencing techniques will help preserve endangered species from extinction. One of these is the so-called Tasmanian devil, a ferocious marsupial that is now under threat from a mysterious, contagious tumor: Devil Facial Tumor Disease (DFTD). ''We are sequencing two specimens, one with the disease and another that seems immune, and hope to use the differences to guide a breeding program,'' he says.
Miller acknowledges that he owes much of his success to ''great'' collaborators, from Myers and Lipman in the late 1980s to Haussler and his UCSC colleagues Jim Kent and Tom Pringle. And it may be that great collaborators make each other. ''Time and time again, Webb has made major contributions and taken little credit for himself, preferring to put younger researchers in the limelight, whether or not they were his students. I've never worked with a more generous collaborator,'' says Haussler.
Overton Prize: Trey Ideker
The ISCB Overton Prize was established in 2001 in memory of G. Christian Overton, a major contributor to the field of bioinformatics and a member of the ISCB Board of Directors who died suddenly the previous year. The Prize is awarded for outstanding accomplishment to a scientist in early-to mid-career who has already made a significant contribution to the field of computational biology. Trey Ideker, winner of the 2009 ISCB Overton Prize, was, like Miller, initially trained in computer science. His decision to move into bioinformatics for his graduate studies was taken for more ideological than scientific reasons. ''I had been working for the defense industry as a college student, and then in my first professional job, and while it is fascinating to model the movement of flying objects, I didn't want to spend my career making bombs. I therefore started looking for alternative ways to use my computing knowledge, including in molecular biology,'' recalls Ideker. A friend who was a molecular biologist in graduate school gave him the names of potential advisors, one of whom was Leroy Hood, co-founder of the Institute of Systems Biology (ISB) in Seattle, Washington. In 1996, and before the ISB was founded, Ideker moved to Seattle to join Hood as one of his first graduate students there. This move set the stage for a career that has already produced some groundbreaking work in the area of network biology.
Ideker's graduate studies coincided with the later years of the Human Genome Project. ''When I joined the lab, everyone there was working on sequence analysis,'' he remembers. ''I was working with a talented physician and postdoc, Pete Nelson, who was studying the pathways in cells that led to the development of prostate cancer. I started trying to model these pathways; this project fell on its face, as it was far too complex for a single graduate student, but the ideas it generated have become the basis for my whole career.'' Working closely with Hood, he-while still a student-was one of the first to publish an integrated computational model of a metabolic network; this paper [6] , published in 2001, has already been cited more than 850 times. With this very promising start, he understandably had many offers of positions as an independent group leader. He initially moved to the prestigious Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, before family drew him back to the West Coast. He is now settled at the University of California San Diego (UCSD) as an associate professor. ''UCSD is a fantastic place to do science. I can't imagine being more productive anywhere else. The growth of biotechnology in the San Diego area in recent years has been overwhelming.'' While at the Whitehead Institute and in collaboration with others looking at similar problems, Ideker further developed a prototype network modelling program that he had worked on in Hood's lab into what is now the widely used online tool Cytoscape [7] . ''We decided to pool our ideas and resources rather than reinventing the wheel,'' he says. Cytoscape is now freely available under an open source license, and this has attracted a far larger pool of both users and developers than would have been attracted to a commercial enterprise.
Ideker continues to be involved in the Cytoscape project, and since moving to San Diego his research has become focused on comparing networks between and within species. This work has already made important contributions beyond systems biology and has convinced Aviv Regev, his immediate predecessor as winner of the ISCB Overton Prize, of its significance. ''Trey's work has epitomized the power of integrating innovative computational methods with cutting-edge genomics. His pioneering work has set a model for doing systems biology that has been followed by numerous groups and has impacts for understanding the evolution of biological systems and for treating disease. '' In the 1990s, bioinformatics was dominated by DNA and protein sequences, with about 95% of its effort going into sequence mining and comparison. Ideker believes that networks are at the next level of complexity from sequences and that similar techniques can and should be used for analyzing them. ''It was obvious to me that we needed a searching and comparison tool that would be something like BLAST for networks,'' he says. The PathBLAST program [8] does just that, and the ideas behind it have spawned a number of similar tools.
More recently, Ideker has been turning his attention to medical applications of network modeling. He has compared the complete map of protein-protein interactions for the malaria parasite Plasmodium falciparum, generated using the yeast-twohybrid method, against other eukaryotic networks, and proposed unique features of its metabolism that might be targeted in designing drugs against this destructive disease [9] . He has also showed that grouping proteins into pathways and taking the average of the levels of each protein in a single pathway can add 8%-9% to the accuracy of prognostic predictions in breast cancer [10] . And he is about to take his involvement in medical applications to a new level, as, in mid-2009, he takes up the position of head of genetics at a new institute within the University of California San Diego School of Medicine. ''I will be moving from the periphery into the center of genomicsbased medical research,'' he says. ''My vision is to integrate network analysis into medicine and develop useful clinical tools.' ' Ideker's career has already been marked by conspicuous success, and he is wellplaced to succeed in this next challenge as well. He adds his Overton Prize to a list of honors that includes recognition by MIT's Technology Review as one of the top ten innovators of 2006. The ISCB Awards Committee members couldn't agree more.
Additional Information
These ISCB award winners will be joined by six other distinguished keynote speakers at the ISMB/ECCB 2009 conference in Stockholm, Sweden, in late June. The conference will also feature halfday special sessions on emerging topics, full-day special interest group meetings, highlights presentations of research published during the previous year with recent updates, technology demonstrations and workshops, poster sessions, an art-in-science exhibition, vendor exhibits, and several networking events. The conference organizers anticipate an attendance of more than 1,400 scientists and are currently finalizing an agenda that is expected to offer more than 150 oral presentations. For the full conference program and registration information, please visit http://www.iscb.org/ismbeccb2009/index. php.
To read more about each of the past winners of ISCB's Accomplishment by a Senior Scientist Award and Overton Prize, please see http://www.iscb.org/iscb-awards.
